![Kin Yip Leung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 30/06/2026
Kin Yip Leung is currently an Independent Director at NovoCure Ltd. since 2011.
Former roles include Independent Director at Curia Global, Inc. from 2010 to 2016; Director at Delcath Systems, Inc. in 2014; Director at NanoMed Pharmaceuticals, Inc.; Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2016 to 2019; Principal at Bristol Myers Squibb Co. from 1990 to 1999; EVP, President-Oncology & Diabetes Business at OSI Pharmaceuticals, Inc. from 2003 to 2010; Group Vice President-Global Prescription Business at Pharmacia Corp.
from 1999 to 2003; and Member at C-Change.
Education includes undergraduate studies at The University of Texas at Austin and graduate studies at the University of Wisconsin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NOVOCURE LTD. 0,09 % | 03/06/2026 | 101.109 ( 0,09 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVOCURE LIMITED | Director/Miembro de la Junta | 05/08/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Director/Miembro de la Junta | 09/05/2019 |
| ALBANY MOLECULAR RESEARCH, INC. | Director/Miembro de la Junta | 04/02/2016 |
| DELCATH SYSTEMS, INC. | Presidente | 15/09/2014 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2010 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01/04/2003 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Curia Global, Inc.
 Curia Global, Inc. BiotechnologyHealth Technology Operates as a global contract research and manufacturing company that provides drug discovery, development & production services | Health Technology |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
NanoMed Pharmaceuticals, Inc.
 NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C-Change
 C-Change Other Consumer ServicesConsumer Services C-Change is a private company based in Washington, DC. C-Change was founded by Kevin Sharps, Lynn L. Davison. | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
